Your browser doesn't support javascript.
loading
Effects of dalteparin on anti-Xa activities cannot be predicted in critically ill COVID-19 patients.
van der Heijden, Charlotte D C C; Ter Heine, Rob; Kooistra, Emma J; Brüggemann, Roger J; Walburgh Schmidt, Jesper W J; de Grouw, Elke P L M; Frenzel, Tim; Pickkers, Peter; Leentjens, Jenneke.
  • van der Heijden CDCC; Department of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Ter Heine R; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
  • Kooistra EJ; Department of Intensive Care, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Brüggemann RJ; Department of Intensive Care, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Walburgh Schmidt JWJ; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
  • de Grouw EPLM; Department of Clinical Chemistry, Radboud University Medical Center, the Netherlands.
  • Frenzel T; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
  • Pickkers P; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
  • Leentjens J; Department of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Br J Clin Pharmacol ; 88(6): 2982-2987, 2022 06.
Article en En | MEDLINE | ID: mdl-34965610
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tromboembolia Venosa / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tromboembolia Venosa / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article